AF
CHRS icon

Allworth Financial’s Coherus Oncology CHRS Stock Holding History

Allworth Financial’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07K Buy
2,190
+1,344
+159% +$2.19K ﹤0.01% 4341
2026
Q1 		$1.43K Buy
846
+784
+1,265% +$1.39K ﹤0.01% 4458
2025
Q4 		$89 Buy
62
+52
+520% +$76 ﹤0.01% 4794
2025
Q3 		$17 Buy
+10
New +$11 ﹤0.01% 4839
2023
Q4 		– Sell
-30
Closed -$113 – 3488
2023
Q3 		$113 Sell
30
-70
-70% -$323 ﹤0.01% 3333
2023
Q2 		$427 Buy
+100
New +$590 ﹤0.01% 2925
2022
Q4 		– Sell
-75
Closed -$1K – 3039
2022
Q3 		$1K Buy
+75
New +$759 ﹤0.01% 2335

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Allworth Financial's CHRS Position: Q2 2026 in Review

Allworth Financial increased its Coherus Oncology (CHRS) stake by 159% in Q2 2026, buying an estimated $2.19K and bringing the position to 2,190 shares worth $3.07K. The position accounts for ﹤0.01% of the portfolio, ranked #4341.

Allworth Financial first reported a position in CHRS in Q3 2022 and has held it in 7 quarters since. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Allworth Financial held 2,190 shares of Coherus Oncology worth $3.07K as of Q2 2026.
  • Allworth Financial bought 1,344 Coherus Oncology shares in Q2 2026, an estimated $2.19K.
  • Coherus Oncology made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4341 holding.
  • Allworth Financial first reported a position in Coherus Oncology in Q3 2022 and has held it in 7 quarters since.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.